
Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript
Medifast NYSE: MED reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1 medicat